The overall score for this website.
How accessible the website is to mobile and disabled users.
The following tests contribute to this score:
How satisfying the website is likely to be for users.
The following tests contribute to this score:
How well marketed, and popular the website is.
The following tests contribute to this score:
How well designed and built the website is.
The following tests contribute to this score:
Nibbler tested a sample of 5 pages from this website at 00:18 on 2 May 2024 (BST).
0% of pages are optimised for printing
Page | |
nimml.org/ | Not detected |
nimml.org/about | Not detected |
nimml.org/people/team-nimml | Not detected |
nimml.org/research | Not detected |
nimml.org/modeling | Not detected |
404 page
Compression
Link URL | Link text | Page URL |
nimml.org/.../nimml-institute-presents-pioneering-research-on-immunometabolic-mechanisms | NIMML Institute Presents Pioneering Research on Immunometabolic Mechanisms Related to the Pharmacological Activation of LANCL Receptors at Immunology2024, the Annual Meeting of the American Association of Immunologists | nimml.org/ |
academic.oup.com/.../5488461?redirectedFrom=fulltext | The Safety, Tolerability, and Pharmacokinetics Profile of BT-11, an Oral, Gut-Restricted Lanthionine Synthetase C-Like 2 Agonist Investigational New Drug for Inflammatory Bowel Disease: A Randomized, Double-Blind, Placebo-Controlled Phase I Clinical Trial | nimml.org/about |
Rendering Chart...
Page | Characters | Words |
nimml.org/ | 3312 | 376 |
nimml.org/about | 6740 | 868 |
nimml.org/people/team-nimml | 18088 | 2453 |
nimml.org/research | 2183 | 222 |
nimml.org/modeling | 1433 | 119 |
URL | Heading | Level |
nimml.org/ | In The News | H2 |
nimml.org/ | Translational and Clinical Science | H2 |
nimml.org/ | Entrepreneurship | H2 |
nimml.org/ | Modeling and AI | H2 |
nimml.org/ | NIMML Institute Presents Pioneering Research on Immunometabolic Mechanisms Related to the Pharmacological Activation of LANCL Receptors at Immunology2024, the Annual Meeting of the American Association of Immunologists | H3 |
nimml.org/ | NIMML Institute’s TITAN-X A.I.-Powered Precision Medicine Platform Validated through AbbVie’s Acquisition of Landos Biopharma and Lead Clinical Candidate NX-13 | H3 |
nimml.org/ | NIMML Announces Publication on the Safety, Efficacy and Novel LANCL2 Mechanism of Action of Omilancor in Inflammatory Bowel Diseases | H3 |
nimml.org/ | NIMML Presents Positive First-in-Human Data of NIM-1324, a Phase 2 Candidate for Systemic Lupus Erythematosus at the American College of Rheumatology Convergence 2023 (#ACR23) | H3 |
nimml.org/ | NIMML Announces Positive Results of Omilancor Clinical Trials in Ulcerative Colitis and Crohn’s Disease at the American College of Gastroenterology 2023 Annual Scientific Meeting | H3 |
nimml.org/ | The NIMML Institute Announces Publication of a Study in Inflammatory Bowel Diseases | H3 |
nimml.org/ | NIMML Institute and NImmune Biopharma Partner to Advance Precision Medicine Research for Autoimmune Diseases | H3 |
nimml.org/ | The NIMML Institute Founder Launches NImmune Biopharma to Develop Late-Stage Breakthrough Immunoregulatory Medicines for Autoimmune Diseases | H3 |
nimml.org/ | Landos Biopharma to Present at the 38th Annual J.P. Morgan Healthcare Conference | H3 |
nimml.org/ | NIMML Announces Publication of New Mechanistic Insights on the Metabolic Control of Inflammation and Infection in Scientific Reports | H3 |
nimml.org/ | NIMML Launches A.I. Powered TITAN-X Platform to Accelerate Development of Precision Immunology Therapeutics | H3 |
nimml.org/ | The NIMML Institute Launches New Tool for Rapidly Analyzing Host Metabolic Profiles from Global Transcriptomics Datasets | H3 |
nimml.org/ | Clinical | H6 |
nimml.org/ | Pig Models | H6 |
nimml.org/ | Media & Press Kit | H6 |
nimml.org/ | ENISI Helicobacter Pylori Model | H6 |
nimml.org/ | CDiff Computational Model Archive | H6 |
nimml.org/ | EAEC Computational Model | H6 |
nimml.org/ | Macrophage Computational Model Archive | H6 |
nimml.org/ | COPASI Helicobacter Pylori Computational Model Archive | H6 |
nimml.org/ | CD4+ T Cell Model Archive | H6 |
nimml.org/ | Immunology | H6 |
nimml.org/ | Animal Models | H6 |
nimml.org/ | Infectious Diseases | H6 |
nimml.org/ | Immune Mediated Diseases | H6 |
nimml.org/ | Chronic Inflammatory Diseases | H6 |
nimml.org/ | Nutritional Immunology | H6 |
nimml.org/ | Drug Development | H6 |
nimml.org/ | Data | H6 |
nimml.org/ | Computational Models | H6 |
nimml.org/ | Tools | H6 |
nimml.org/ | Projects | H6 |
nimml.org/ | Immunoinformatics | H6 |
nimml.org/about | About | H1 |
nimml.org/about | Director's page | H1 |
nimml.org/about | Mission, Vision, Values | H1 |
nimml.org/about | Careers | H1 |
nimml.org/about | Donations | H1 |
nimml.org/about | About NIMML | H2 |
nimml.org/about | NIMML History | H2 |
nimml.org/about | Our Mission | H2 |
nimml.org/about | Our Vision | H2 |
nimml.org/about | Our Values | H2 |
nimml.org/about | Open positions | H2 |
nimml.org/about | What NIMML Students Say | H2 |
nimml.org/about | Clinical | H6 |
nimml.org/about | Pig Models | H6 |
nimml.org/about | Media & Press Kit | H6 |
nimml.org/about | ENISI Helicobacter Pylori Model | H6 |
nimml.org/about | CDiff Computational Model Archive | H6 |
nimml.org/about | EAEC Computational Model | H6 |
nimml.org/about | Macrophage Computational Model Archive | H6 |
nimml.org/about | COPASI Helicobacter Pylori Computational Model Archive | H6 |
nimml.org/about | CD4+ T Cell Model Archive | H6 |
nimml.org/about | Immunology | H6 |
nimml.org/about | Animal Models | H6 |
nimml.org/about | Infectious Diseases | H6 |
nimml.org/about | Immune Mediated Diseases | H6 |
nimml.org/about | Chronic Inflammatory Diseases | H6 |
nimml.org/about | Nutritional Immunology | H6 |
nimml.org/about | Drug Development | H6 |
nimml.org/about | Data | H6 |
nimml.org/about | Computational Models | H6 |
nimml.org/about | Tools | H6 |
nimml.org/about | Projects | H6 |
nimml.org/about | Immunoinformatics | H6 |
nimml.org/people/team-nimml | Collaborators | H1 |
nimml.org/people/team-nimml | Team NIMML | H1 |
nimml.org/people/team-nimml | Clinical | H6 |
nimml.org/people/team-nimml | Pig Models | H6 |
nimml.org/people/team-nimml | Media & Press Kit | H6 |
nimml.org/people/team-nimml | ENISI Helicobacter Pylori Model | H6 |
nimml.org/people/team-nimml | CDiff Computational Model Archive | H6 |
nimml.org/people/team-nimml | EAEC Computational Model | H6 |
nimml.org/people/team-nimml | Macrophage Computational Model Archive | H6 |
nimml.org/people/team-nimml | COPASI Helicobacter Pylori Computational Model Archive | H6 |
nimml.org/people/team-nimml | CD4+ T Cell Model Archive | H6 |
nimml.org/people/team-nimml | Immunology | H6 |
nimml.org/people/team-nimml | Animal Models | H6 |
nimml.org/people/team-nimml | Infectious Diseases | H6 |
nimml.org/people/team-nimml | Immune Mediated Diseases | H6 |
nimml.org/people/team-nimml | Chronic Inflammatory Diseases | H6 |
nimml.org/people/team-nimml | Nutritional Immunology | H6 |
nimml.org/people/team-nimml | Drug Development | H6 |
nimml.org/people/team-nimml | Data | H6 |
nimml.org/people/team-nimml | Computational Models | H6 |
nimml.org/people/team-nimml | Tools | H6 |
nimml.org/people/team-nimml | Projects | H6 |
nimml.org/people/team-nimml | Immunoinformatics | H6 |
nimml.org/research | Explore our research In... | H1 |
nimml.org/research | Drug Development | H3 |
nimml.org/research | Nutritional Immunology | H3 |
nimml.org/research | Immune Mediated Diseases | H3 |
nimml.org/research | Infectious Diseases | H3 |
nimml.org/research | Chronic Diseases | H3 |
nimml.org/research | Computational Immunology | H3 |
nimml.org/research | Clinical | H6 |
nimml.org/research | Pig Models | H6 |
nimml.org/research | Media & Press Kit | H6 |
nimml.org/research | ENISI Helicobacter Pylori Model | H6 |
nimml.org/research | CDiff Computational Model Archive | H6 |
nimml.org/research | EAEC Computational Model | H6 |
nimml.org/research | Macrophage Computational Model Archive | H6 |
nimml.org/research | COPASI Helicobacter Pylori Computational Model Archive | H6 |
nimml.org/research | CD4+ T Cell Model Archive | H6 |
nimml.org/research | Immunology | H6 |
nimml.org/research | Animal Models | H6 |
nimml.org/research | Infectious Diseases | H6 |
nimml.org/research | Immune Mediated Diseases | H6 |
nimml.org/research | Chronic Inflammatory Diseases | H6 |
nimml.org/research | Nutritional Immunology | H6 |
nimml.org/research | Drug Development | H6 |
nimml.org/research | Data | H6 |
nimml.org/research | Computational Models | H6 |
nimml.org/research | Tools | H6 |
nimml.org/research | Projects | H6 |
nimml.org/research | Immunoinformatics | H6 |
nimml.org/modeling | Integrative Modeling | H1 |
nimml.org/modeling | Computational Models | H2 |
nimml.org/modeling | Animal Models | H2 |
nimml.org/modeling | Tools | H2 |
nimml.org/modeling | Clinical | H6 |
nimml.org/modeling | Pig Models | H6 |
nimml.org/modeling | Media & Press Kit | H6 |
nimml.org/modeling | ENISI Helicobacter Pylori Model | H6 |
nimml.org/modeling | CDiff Computational Model Archive | H6 |
nimml.org/modeling | EAEC Computational Model | H6 |
nimml.org/modeling | Macrophage Computational Model Archive | H6 |
nimml.org/modeling | COPASI Helicobacter Pylori Computational Model Archive | H6 |
nimml.org/modeling | CD4+ T Cell Model Archive | H6 |
nimml.org/modeling | Immunology | H6 |
nimml.org/modeling | Animal Models | H6 |
nimml.org/modeling | Infectious Diseases | H6 |
nimml.org/modeling | Immune Mediated Diseases | H6 |
nimml.org/modeling | Chronic Inflammatory Diseases | H6 |
nimml.org/modeling | Nutritional Immunology | H6 |
nimml.org/modeling | Drug Development | H6 |
nimml.org/modeling | Data | H6 |
nimml.org/modeling | Computational Models | H6 |
nimml.org/modeling | Tools | H6 |
nimml.org/modeling | Projects | H6 |
nimml.org/modeling | Immunoinformatics | H6 |
100% of pages use analytics
Multiple Analytics Solutions
Software Name |
Google Analytics |
100% of pages have defined titles
0% of page titles are weak
0% of images have a clearly defined size
No images are being resized by the browser
This is how this website will look in Google search listings:
Nutritional Immunology and Molecular Medicine Laboratory
nimml.org/
The NIMML tackles unsolved challenges in complex human diseases with unmet clinical needs. We combine advanced computational technologies with pre-clinical and ...
Page URL | Name | Content |
nimml.org/ | keywords | nimml, Data Science, Artificial Intelligence, Crohn's Disease, helicobacter pylori, science, Precision Medicines, Ulcerative colitis, Immunology |
nimml.org/ | description | The NIMML tackles unsolved challenges in complex human diseases with unmet clinical needs. We combine advanced computational technologies with pre-clinical and clinical experimentation to catalyze translation of scientific discoveries into commercial applications that address unmet clinical or consumer needs. |
nimml.org/ | viewport | width=device-width, initial-scale=1.0, maximum-scale=1 |
nimml.org/ | google-site-verification | 5L9IhAt3Ja_FwCc2bq0Jf19NE5VDitFUtmYq4C3TVhA |
nimml.org/about | keywords | nimml, Data Science, Artificial Intelligence, Crohn's Disease, helicobacter pylori, science, Precision Medicines, Ulcerative colitis, Immunology |
nimml.org/about | description | The NIMML tackles unsolved challenges in complex human diseases with unmet clinical needs. We combine advanced computational technologies with pre-clinical and clinical experimentation to catalyze translation of scientific discoveries into commercial applications that address unmet clinical or consumer needs. |
nimml.org/about | viewport | width=device-width, initial-scale=1.0, maximum-scale=1 |
nimml.org/about | google-site-verification | 5L9IhAt3Ja_FwCc2bq0Jf19NE5VDitFUtmYq4C3TVhA |
nimml.org/people/team-nimml | keywords | nimml, Data Science, Artificial Intelligence, Crohn's Disease, helicobacter pylori, science, Precision Medicines, Ulcerative colitis, Immunology |
nimml.org/people/team-nimml | description | The NIMML tackles unsolved challenges in complex human diseases with unmet clinical needs. We combine advanced computational technologies with pre-clinical and clinical experimentation to catalyze translation of scientific discoveries into commercial applications that address unmet clinical or consumer needs. |
nimml.org/people/team-nimml | viewport | width=device-width, initial-scale=1.0, maximum-scale=1 |
nimml.org/people/team-nimml | google-site-verification | 5L9IhAt3Ja_FwCc2bq0Jf19NE5VDitFUtmYq4C3TVhA |
nimml.org/research | keywords | nimml, Data Science, Artificial Intelligence, Crohn's Disease, helicobacter pylori, science, Precision Medicines, Ulcerative colitis, Immunology |
nimml.org/research | description | The NIMML tackles unsolved challenges in complex human diseases with unmet clinical needs. We combine advanced computational technologies with pre-clinical and clinical experimentation to catalyze translation of scientific discoveries into commercial applications that address unmet clinical or consumer needs. |
nimml.org/research | viewport | width=device-width, initial-scale=1.0, maximum-scale=1 |
nimml.org/research | google-site-verification | 5L9IhAt3Ja_FwCc2bq0Jf19NE5VDitFUtmYq4C3TVhA |
nimml.org/modeling | keywords | nimml, Data Science, Artificial Intelligence, Crohn's Disease, helicobacter pylori, science, Precision Medicines, Ulcerative colitis, Immunology |
nimml.org/modeling | description | The NIMML tackles unsolved challenges in complex human diseases with unmet clinical needs. We combine advanced computational technologies with pre-clinical and clinical experimentation to catalyze translation of scientific discoveries into commercial applications that address unmet clinical or consumer needs. |
nimml.org/modeling | viewport | width=device-width, initial-scale=1.0, maximum-scale=1 |
nimml.org/modeling | google-site-verification | 5L9IhAt3Ja_FwCc2bq0Jf19NE5VDitFUtmYq4C3TVhA |
Page URL | Name | Content |
nimml.org/ | X-UA-Compatible | IE=edge,chrome=1 |
nimml.org/about | X-UA-Compatible | IE=edge,chrome=1 |
nimml.org/people/team-nimml | X-UA-Compatible | IE=edge,chrome=1 |
nimml.org/research | X-UA-Compatible | IE=edge,chrome=1 |
nimml.org/modeling | X-UA-Compatible | IE=edge,chrome=1 |
Every URL is well written
Last updated April 10, 2024
This website does not appear to be associated with a Twitter account.
Insites creates professional website reports that can be shared with your clients.
How does Insites compare?
Nibbler | Insites | |
---|---|---|
Tests | 17 fixed tests | 50+ testsCovers SEO, SEM, Google My Business, reviews, social media and much more |
Add your branding | No | Yes |
Export & share | No | PDF & link |
Lead generation | No | Embed on your site |
Competitor audits | No | Yes |
Test as a batch | No | Yes |
Integrations + API | No | Yes |
Multi-lingual | No | 20+ languages |
Try it free |